CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01232790
NCT01232790N/ACompleted
CompareCT.gov

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

Yale University·interventional·Posted Nov 2, 2010·Updated Dec 1, 2015

In Brief

A clinical study evaluating N-Acetylcysteine and Placebo for Schizophrenia. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effects of the amino acid supplement N-Acetylcysteine versus placebo on working memory and other cognitive functions in persons with a diagnosis of schizophrenia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
CollaboratorsNational Alliance for Research on Schizophrenia and Depression

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2, 2010
Enrollment StartFeb 1, 2010
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.7 years ago

Interventions

N-Acetylcysteinedietary

N-acetylcysteine 1200mg bid for 3 days

Placebodrug

Placebo